bioAffinity Technologies, Inc. 8-K

What Happened

• bioAffinity Technologies, Inc. announced that its 2026 Annual Meeting of Stockholders will be held on April 30, 2026 at the company’s principal executive offices: 3300 Nacogdoches Road, Suite 216, San Antonio, TX 78217. The company said full meeting details will be included in a definitive proxy statement to be filed with the SEC.
• The company expects to include the proposals from its Special Meeting of Stockholders (originally convened December 19, 2025) that was adjourned without any business conducted because there was not a sufficient number of shares present in person or by proxy to constitute a quorum.

Key Details

• Annual meeting date: April 30, 2026.
• Meeting location: 3300 Nacogdoches Road, Suite 216, San Antonio, TX 78217.
• Special Meeting originally convened: December 19, 2025 — adjourned with no business due to lack of quorum.
• Deadline for stockholder notice to propose business or nominate a director: written notice must be received at the company’s principal executive offices by February 14, 2026 (per the company’s Amended and Restated Bylaws).

Why It Matters

• Investors should note the meeting date and the Feb 14, 2026 deadline if they plan to nominate directors or submit proposals — missing the deadline may preclude inclusion. The company’s proxy statement will provide voting items and additional details.
• The adjournment of the December 19, 2025 Special Meeting (no quorum) means previously planned proposals were not voted on then and are expected to be considered at the April 30, 2026 Annual Meeting.